Leverty Financial Group, LLC Synthetic Biologics, Inc. Transaction History

Leverty Financial Group, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 20, 2022	SELL	$2.3 - $4.3 $328 - $614	-143 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$2.7 - $4.5 $386 - $643	143 New	143 $0

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Leverty Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leverty Financial Group, LLC with notifications on news.